Health and Fitness Health and Fitness
Thu, July 15, 2010
[ 02:00 PM ] - Market Wire
Cytori Therapeutics, Embraer, Intel, NVIDIA and Advanced Micro Devices
[ 02:00 PM ] - Market Wire
Vivus, Roche, GlaxoSmithKline, Abbott and Orexigen Therapeutics
[ 01:50 PM ] - Market Wire
BioScrip, Inc. to Host 2010 Second Quarter Earnings Call
[ 01:17 PM ] - Market Wire
WellTek Subsidiary Forms Strategic Partnership With Global Network Marketing Company
[ 01:07 PM ] - Market Wire
3P International Energy Corp. (formerly Colonnade .. apital Corp. Changes Its Name to 3P International
[ 12:39 PM ] - Market Wire
Kendall Law Group Investigates NBTY, Inc. Acquisition for Shareholders
[ 12:26 PM ] - Market Wire
Arius3D Corp. Completes $245,000 Private Placement
[ 09:48 AM ] - Market Wire
Remedent Reports Fourth Quarter and Year End Resu .. nference Call at 11:00 A.M. EST, Tuesday, July 20
[ 09:33 AM ] - Market Wire
Response Genetics Inc. fija fecha para su junta a .. s 2010 y anuncia lista de candidatos a consejeros
[ 09:33 AM ] - Market Wire
Response Genetics Inc. bepaalt datum van jaarlijk .. g 2010 en kondigt lijst bestuursgenomineerden aan
[ 09:15 AM ] - Market Wire
Aetna Suppliers Meet Health Care Coverage Challenge to Reduce Number of Uninsured
[ 09:05 AM ] - Market Wire
Bard to Host Earnings Conference Call on July 22, 2010
[ 07:04 AM ] - Market Wire
Bernstein Liebhard LLP Announces Investigation of Acquisition of NBTY, Inc. by the Carlyle Group
[ 07:00 AM ] - Market Wire
CNS Response Announces Pending Action in California District Court Dismissed
[ 06:15 AM ] - Market Wire
Healthnostics Repurchases 150 Million Shares of Its Stock
[ 05:30 AM ] - Market Wire
Ligand Launches New Corporate Web Site
[ 05:00 AM ] - Market Wire
DaVita Announces New Permanent Headquarters Building Adjacent to Millennium Bridge
[ 05:00 AM ] - Market Wire
Il Consiglio di amministrazione annuncia che Resp .. la data per la?assemblea annuale degli azionisti
[ 05:00 AM ] - Market Wire
Response Genetics Inc. Sets Date for 2010 Annual Meeting of Stockholders, Announces Board Slate
[ 05:00 AM ] - Market Wire
Sunesis Issued European Patent Covering Voreloxin Combination
[ 04:46 AM ] - Market Wire
Best Cancer Vaccine? Answer May Surprise Investors
[ 04:30 AM ] - Market Wire
Geron Provides Update on Telomerase Activation Program
[ 01:04 AM ] - Market Wire
Genoptix, Inc. to Announce Second Quarter 2010 Financial Results
Wed, July 14, 2010
[ 11:00 PM ] - Market Wire
Trading and Business Update
[ 04:20 PM ] - Market Wire
Kinetic Concepts, Inc. Announces Date of Its Seco .. Quarter 2010 Earnings Release and Conference Call
[ 03:57 PM ] - Market Wire
Indicator Minerals Closes Final Tranche of Private Placement
[ 03:30 PM ] - Market Wire
Wright Medical Group, Inc. to Host Second Quarter 2010 Earnings Conference Call
[ 03:10 PM ] - Market Wire
Gilead Sciences Files Patent Infringement Lawsuit Against Lupin Limited
[ 02:25 PM ] - Market Wire
Prize Mining Corporation: Annual General and Special Shareholders' Meeting Update
[ 01:30 PM ] - Market Wire
The Medicines Company to Announce Second Quarter .. 010 Financial Results on Wednesday, July 28, 2010

The Medicines Company to Announce Second Quarter 2010 Financial Results on Wednesday, July 28, 2010


Published on 2010-07-14 13:40:41 - Market Wire
  Print publication without navigation


PARSIPPANY, NJ--(Marketwire - July 14, 2010) - The Medicines Company (NASDAQ: [ MDCO ]) has scheduled its quarterly conference call for Wednesday, July 28, 2010 at 8:30 a.m. Eastern Time to discuss second quarter 2010 financial results and operational developments.

The conference call will be available via phone and webcast. The dial in information is listed below:

Domestic Dial In:866.362.5158
International Dial In:617.597.5397
Passcode for both dial in numbers:83135911

Replay is available from 11:30 a.m. Eastern Time following the conference call through August 11, 2010. To hear a replay of the call dial 888-286-8010 (domestic) and 617-801-6888 (international). Passcode for both dial in numbers is 37130585.

This call is being webcast and can be accessed at The Medicines Company website at [ www.themedicinescompany.com ].

About The Medicines Company

The Medicines Company (NASDAQ: [ MDCO ]) is focused on advancing the treatment of critical care patients through the delivery of innovative, cost-effective medicines to the worldwide hospital marketplace. The Company markets Angiomax® (bivalirudin) in the United States and other countries for use in patients undergoing coronary angioplasty, and Cleviprex® (clevidipine butyrate) injectable emulsion in the United States for the reduction of blood pressure when oral therapy is not feasible or not desirable. The Company's website is [ www.themedicinescompany.com ].

Contributing Sources